Mazzantini M - Search Results

1

Long-term prospective study of osteoporotic patients treated with percutaneous vertebroplasty after fragility fractures.

Mazzantini M, Carpeggiani P, d'Ascanio A, Bombardieri S, Di Munno O. Mazzantini M, et al. Osteoporos Int. 2011 May;22(5):1599-607. doi: 10.1007/s00198-010-1341-z. Epub 2010 Jul 27. Osteoporos Int. 2011. PMID: 20661546

2

Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.

Di Munno O, Imbimbo B, Mazzantini M, Milani S, Occhipinti G, Pasero G. Di Munno O, et al. Among authors: mazzantini m. J Rheumatol. 1995 Aug;22(8):1492-8. J Rheumatol. 1995. PMID: 7473472 Clinical Trial.

3

Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis.

Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A, Ferri C. Di Munno O, et al. Among authors: mazzantini m. Clin Rheumatol. 1995 Jul;14(4):407-12. doi: 10.1007/BF02207673. Clin Rheumatol. 1995. PMID: 7586976

4

[Short-term effects of salmon calcitonin rectal administration in women with involutive osteoporosis].

Mazzantini M, Nasti P, Mandolesi MC, Di Munno O. Mazzantini M, et al. Minerva Endocrinol. 1994 Dec;19(4):175-6. Minerva Endocrinol. 1994. PMID: 7739471 Clinical Trial. Italian. No abstract available.

5

Clinical equivalence between deflazacort oral drops and tablets in active rheumatoid arthritis.

Di Munno O, Mazzantini M, Milani S, Pasero G. Di Munno O, et al. Among authors: mazzantini m. Clin Rheumatol. 1999;18(2):140-4. doi: 10.1007/s100670050072. Clin Rheumatol. 1999. PMID: 10357120 Clinical Trial.

6

Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate.

Mazzantini M, Di Munno O, Incerti-Vecchi L, Pasero G. Mazzantini M, et al. Clin Exp Rheumatol. 2000 May-Jun;18(3):327-31. Clin Exp Rheumatol. 2000. PMID: 10895369 Clinical Trial.

7

Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.

Mazzantini M, Di Munno O, Metelli MR, Bulleri M, Giordani R. Mazzantini M, et al. Aging Clin Exp Res. 2002 Jun;14(3):197-201. doi: 10.1007/BF03324436. Aging Clin Exp Res. 2002. PMID: 12387527 Clinical Trial.

8

Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study.

di Munno O, Mazzantini M, Sinigaglia L, Bianchi G, Minisola G, Muratore M, la Corte R, di Matteo L, Canesi B, Caminiti M, Broggini M, Adami S. di Munno O, et al. Among authors: mazzantini m. J Rheumatol. 2004 Jul;31(7):1305-9. J Rheumatol. 2004. PMID: 15229948

9

Risk factors for osteoporosis in female patients with systemic lupus erythematosus.

Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S. Di Munno O, et al. Among authors: mazzantini m. Lupus. 2004;13(9):724-30. doi: 10.1191/0961203303lu1097oa. Lupus. 2004. PMID: 15485112 Review.

10

Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.

Mazzantini M, Di Munno O, Sinigaglia L, Bianchi G, Rossini M, Mela Q, Del Puente A, Frediani B, Cantatore F, Adami S. Mazzantini M, et al. Clin Exp Rheumatol. 2007 Sep-Oct;25(5):709-15. Clin Exp Rheumatol. 2007. PMID: 18078618 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters